Journals / Turkish Computational and Theoretical Chemistry / 2023 / Cilt: 7 Sayı: 3

In silico ADMET, toxicological analysis, molecular docking studies and Molecular dynamics simulation of Afzelin with potential antibacterial effects against Staphylococcus aureus

Pages
10–16
Publication Date
2023-09-03
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results indicated a good affinity of afzelin to the chosen target with the formation of four hydrogen bonds and binding energy of 29.82 KJ/mol.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Afzelin has been designed and tested for its in silico antibacterial activity against DNA gyrase complex of Staphyloccocus aureus.
📊
Key Findings & Data:The results of the toxicity study indicate that afzelin displayed moderate antibacterial potential against staphylococcus aureus with LD50 = 5000 mg/Kg, which is almost four times and a half weaker than that obtained for the commercial antibiotic chloramphenicol.
💡
Conclusion & Impact:Results indicated a good affinity of afzelin to the chosen target with the formation of four hydrogen bonds and binding energy of 29.82 KJ/mol.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Euphorbia falcata L · binding energy · antibacterial activity

Abstract

Afzelin has been designed and tested for its in silico antibacterial activity against DNA gyrase complex of Staphyloccocus aureus. The results of the toxicity study indicate that afzelin displayed moderate antibacterial potential against staphylococcus aureus with LD50 = 5000 mg/Kg, which is almost four times and a half weaker than that obtained for the commercial antibiotic chloramphenicol. The afzelin and the commercial antibiotic chloramphenicol were subjected to docking studies to understand their interaction with DNA gyrase complex of Staphyloccocus aureus. Results indicated a good affinity of afzelin to the chosen target with the formation of four hydrogen bonds and binding energy of 29.82 KJ/mol. ADME study shows that afzelin is not inhibitors of CYP450 IA2, 2C19, 2C9, 2D6, 3A4 isoenzymes which suggests a decrease in their plasma concentrations and a rapid elimination route. Molecular dynamics simulations were performed for 10 ns for afzelin using the gromacs package to assess the conformational stability of protein-ligand complexes during the simulation.

🔖

Cite This Article

LANEZ, E., LANEZ, T., ZEGHEB, N. (2023). In silico ADMET, toxicological analysis, molecular docking studies and Molecular dynamics simulation of Afzelin with potential antibacterial effects against Staphylococcus aureus. Turkish Computational and Theoretical Chemistry, Cilt: 7 Sayı: 3, 10–16. https://ajindex.com/articles/961457

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. V.M. D’Costa, C.E. King, L. Kalan, M. Morar, W.W.L. Sung, C. Schwarz, D. Froese, G. Zazula, F. Calmels, R. Debruyne, Antibiotic resistance is ancient, Nature 477 (2011) 457–461
  2. K. Bhullar, N. Waglechner, A. Pawlowski, K. Koteva, E.D. Banks, M.D. Johnston, H.A. Barton, G.D. Wright, Antibiotic resistance is prevalent in an isolated cave microbiome, PLoS One 7 (2012) e34953- e34953
  3. S.Y. Lee, Y.J. So, M.S. Shin, J.Y. Cho, J. Lee, Antibacterial Effects of Afzelin Isolated from Cornus macrophylla on Pseudomonas aeruginosa, A Leading Cause of Illness in Immunocompromised Individuals, Molecules 19 (2014) 3173-3180
  4. J. Wang, A.M. Sci, M. Cao, B. Fan, T. Zhen, A pre-clinical trial study on afzelin: anti-human lung cancer, anti-cholinesterase, and anti-glucosidase properties, Archives of Medical Science (2021) 1-9
  5. K. Shingnaisui, T. Dey, P. Manna, J. Kalita, Therapeutic potentials of Houttuynia cordata Thunb. against inflammation and oxidative stress: A review, J Ethnopharmacology 220 (2018) 35–43
  6. B.M. Radu, F.B. Epureanu, M. Radu, P.F. Fabene, G. Bertini, Nonsteroidal anti-inflammatory drugs in clinical and experimental epilepsy, Epilepsy Research 131 (2017) 15–27
  7. D.G. Lee, J.S. Lee, N.G. Quilantang, S.D. Jacinto, S. Lee, Determination of Afzelin and Astragalin from Lespedeza cuneata on Aldose Reductase Inhibition, Journal of chromatographic science 59 (2021) 381–387
  8. K.C. Zhu, J.M. Sun, J.G. Shen, J.Z. Jin, F. Liu, X.L. Xu, L. Chen, L.T. Liu, J.J. Lv, Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1, Oncology Letters 10 (2015) 2359–2365
  9. I. Radziejewska, K. Supruniuk, R. Czarnomysy, K. Buzun, A. Bielawska, Anti-Cancer Potential of Afzelin towards AGS Gastric Cancer Cells, Pharmaceuticals (Basel), 14 (2021) 1-16
  10. D. Utepbergenov, U. Derewenda, N. Olekhnovich, G. Szukalska, B. Banerjee, M.K. Hilinski, D.A. Lannigan, P.T. Stukenberg, Z.S. Derewenda, Insights into the inhibition of the p90 ribosomal S6 kinase (RSK) by the flavonol glycoside SL0101 from the 1.5 Å crystal structure of the N-terminal domain of RSK2 with bound inhibitor, Biochemistry 51 (2012) 6499–6510
  11. S. Kumar, A.K. Pandey, Chemistry and biological activities of flavonoids: An overview, The Scientific World Journal 2013 (2013) 1-16
  12. F.M. Afendi, T. Okada, M. Yamazaki, A. Hirai-Morita, Y. Nakamura, K. Nakamura, S. Ikeda, H. Takahas